Credo Technology Group vs. Marvell Technology: Which Semiconductor Stock Is a Better Buy in 2026?

Credo generated nearly $1.3 billion in FY2026 revenue, up 205.7%, and about $472.3 million in net income, while carrying no debt; it trades at 25.6x forward P/E versus Marvell's 55.9x. Marvell reported approximately $8.2 billion of FY2026 revenue, up 42.1%, and $2.7 billion in net income, supported by data-center demand and an Alphabet partnership through 2033. The article favors Credo for its seventh consecutive quarter of triple-digit revenue growth, nearly 50% reported net margins and guidance for more than 85% growth, while noting customer concentration, Taiwan manufacturing exposure and stock-based-compensation-adjusted cash-flow risks for both companies.

Analysis

The relevant distinction is not growth versus value but exposure purity versus platform optionality. CRDO’s economics imply that incremental AI-cluster buildouts are translating unusually directly into earnings; that also makes a single hyperscaler architecture change, inventory digestion, or a shift from active electrical cables toward optics a disproportionately large estimate risk. At a high sales multiple, even a modest deceleration from current growth expectations could drive multiple compression before any meaningful EPS shortfall appears.

MRVL has a more credible path to diversify AI revenue across custom silicon, switching/interconnect, and storage, but its valuation requires execution on customer programs whose revenue ramps tend to be lumpy and whose design-win announcements are not equivalent to volume shipments. The NVIDIA strategic alignment is double-edged: it validates capability, yet increases the risk that MRVL is valued as an AI-platform beneficiary while economically functioning as a lower-margin, customer-concentrated component supplier. Watch gross-margin progression and custom-silicon backlog conversion rather than headline partnership duration.

Second-order, hyperscaler capex remains the common upstream driver, but CRDO and ALAB are more exposed to the mix of scale-out networking and rack-level interconnect, whereas AVGO benefits if customers consolidate around proprietary switching/custom ASIC ecosystems. A transition to denser optical architectures could favor optical-component suppliers and pressure copper-centric attach assumptions; conversely, delayed 1.6T deployments would likely hit smaller connectivity names first. TSM is the lower-beta expression of sustained demand but will not capture the same operating leverage.

Consensus appears to be extrapolating peak AI-networking growth across the entire merchant ecosystem. The better relative trade is to own the company with identifiable program conversion while hedging the high-expectation pure play; this thesis is falsified if CRDO sustains growth and margins through two additional hyperscaler procurement cycles, or if MRVL’s next two reports fail to show data-center growth converting into expanding gross margin and backlog.

Key Decisions for Investors

• Initiate a 3-6 month pair: long MRVL / short CRDO in equal dollar amounts after confirming post-earnings estimate revisions. Target 15-20% relative outperformance from MRVL program-revenue conversion or CRDO growth deceleration; exit if CRDO delivers two consecutive quarters of accelerating revenue growth with stable or higher gross margin.
• Avoid adding outright CRDO exposure ahead of its next earnings print unless channel checks confirm incremental hyperscaler design wins and no active-electrical-cable inventory build. Use a break below prior support or a guide below consensus as a short trigger; a 10-15% downside is plausible on a growth de-rating, with risk capped by a sustained upside guidance revision.
• For a lower-volatility AI connectivity allocation, favor AVGO over CRDO/ALAB for the next 6-12 months. AVGO offers exposure to custom ASIC and switching consolidation; reassess if hyperscaler capex guides weaken or networking revenue misses, which would undermine the architecture-consolidation thesis.
• Set alerts around hyperscaler capex guidance from MSFT, GOOG, ORCL and around TSM advanced-node utilization. A broad capex slowdown is a near-term negative for CRDO, ALAB and MRVL, while a mix shift toward proprietary accelerators/custom silicon would be relatively supportive of MRVL and AVGO.